FDA approves glucose monitoring system

The Food and Drug Administration recently approved the FreeStyle Libre Flash Glucose Monitoring System to be sold in the United States. The Libre is manufactured by Abbott and is currently only available overseas. The system allows patients to view blood sugar every minute of the day without pricking a finger. The device will be available […]

Broccoli design offers clue to improve retinal implants

Researchers at the University of Oregon are currently exploring the possibility that retinal implants with a fractal design might provide the first viable therapy in treating people who have lost vision due to retinal diseases. Implants that are currently being used have not demonstrated the kind of vision restoration that doctors and patients were looking […]

#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1 cause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

Americans’ Greatest Health Fear? Going Blind

A study conducted by the Wilmer Eye Institute at Johns Hopkins University School of Medicine found that most Americans deem loss of vision as the worst thing that could happen to them even when compared to memory loss, loss of speech, hearing or loss of limb or having HIV/AIDS. Despite the fact that most Americans […]

Diabetics more likely to skip eye exams

Despite having a higher risk of developing serious eye diseases that could potentially rob them of their vision, nearly 60 percent of diabetics do not have yearly eye exams. Diabetics are at a greater risk of losing their vision to diabetic retinopathy and the disease can lead to additional blinding eye problems if not caught early and […]

Google’s Artificial Intelligence may save eyesight

Optical Coherence Tomography (OCT) is what is currently used to diagnose diabetic retinopathy and age-related macular degeneration. The problem with this digital scanning method is that it is highly complex and time-consuming for eye care professionals to analyze. This adds up to time lost in diagnosing and treating as early as possible. Aware of this, […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]

Lucentis beats lasers in treating diabetic retinopathy

A study funded by the National Eye Institute determined that Lucentis injections trumped laser therapy in treating proliferative diabetic retinopathy. The study results were published in the Journal of the American Medical Association online. 305 patients were included in the study with half of them receiving monthly Lucentis injections for three months and then only […]

Annual dilated eye exams crucial for diabetic patients

Diabetic patients are encouraged to get an annual dilated eye exam and with November being Diabetic Eye Disease Awareness Month, prevention strategies are being stressed. Diabetes is the leading cause of new cases of blindness in adults. Close monitoring by an eye care professional can help lessen diabetes’ impact on vision and with diabetics being […]

Eylea approved as diabetic retinopathy treatment

The FDA gave its approval for Eylea to be used in the treatment of diabetic retinopathy in patients with diabetic macular edema. Currently one third of diabetic patients over the age of 40 have some variation of the eye disease. Diabetic retinopathy with macular edema can cause abnormal blood vessels to form on the retina’s […]